Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
LI-COR Acquires Anemoment 2022-12-21 02:16
THE BNI FOUNDATION LAUNCHES HUMANITARIAN EFFORT TO SUPPORT CHILDREN IN NEED IN UKRAINE 2022-12-21 02:11
WINNERS OF THE SECOND EVER VINFUTURE PRIZE AWARDS UNVEILED 2022-12-21 02:06
Yili Group Presents Its Biodiversity Conservation Efforts at the UN Biodiversity Conference 2022-12-21 01:32
ViewSonic Converts Stadtwerke Krefeld into a Next-Gen Conference Solution with 216" All-in-One LED Display 2022-12-21 01:00
Sirnaomics Announces Interim Data from Phase I Clinical Trial of RNAi Therapeutic STP707 for Treatment of Multiple Solid Tumors 2022-12-21 00:39
CA Pitching Arena 2022 Winter Edition was held locally in Jakarta for the first time in three years. 2022-12-21 00:11
Sanisure Announces the Acquisition of a Leading Silicone Extrusion Facility in Twinsburg, Ohio 2022-12-21 00:06
Deloitte Receives Multiple Honors at the International Innovation Awards 2022 2022-12-21 00:00
AstraZenca, G42 Healthcare enter strategic partnership to manufacture pharmaceutical products in Abu Dhabi 2022-12-20 23:16
CGTN: New Approaches: How China stimulates enterprises to revive business 2022-12-20 22:55
CGTN: New Approaches : How China pushes COVID-19 vaccine R&D and inoculation 2022-12-20 22:53
SI GROUP LAUNCHES DIGITAL PORTAL FOR GLOBAL PERFORMANCE ADDITIVES PORTFOLIO 2022-12-20 22:48
6,000+ Higer Buses Serve Top Football Event in Qatar 2022-12-20 22:20
WorkForce Software CEO Mike Morini Named in Top 100 Highest-Rated Chief Executive Officers of 2022 by Comparably 2022-12-20 22:00
Daelim Successfully Obtained The Transformer UL/cUL Certification 2022-12-20 21:05
Next Meats, Dr. Foods and ImpacFat ink MOU to propel the development of environmentally friendly foods 2022-12-20 20:22
The First Global Digital Ecosystem Conference 2022 comes to a successful close 2022-12-20 20:18
Altair Leads Seed Funding for Xscape Photonics with $10 Million Investment 2022-12-20 20:00
Kira Pharmaceuticals Announces Clearance to Initiate Phase 2 Evaluation of KP104 in IgA Nephropathy (IgAN) and Complement 3 Glomerulopathy (C3G) in China and Australia 2022-12-20 20:00
1 1301 1302 1303 1304 1305 5295